SCHEMBL17599535

SCHEMBL17599535

Cc1cc(C)c(C)c(S(=O)(=O)Nc2cc(/C=C/C(=O)O)cc3ccccc23)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ HPGD P15428 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ CRHBP P24387 1/20 0.53
▸ CRHR2 Q13324 1/20 0.53
▸ POLB P06746 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ KEAP1 Q14145 6/20 0.44
▸ NFE2L2 Q16236 3/20 0.44
▸ LMNA P02545 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ GAA P10253 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599538 1.00 KDM4E (0.53) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599554 0.85 KMT2A (0.45) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599555 0.85 KMT2A (0.45) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599430 0.77 KMT2A (0.51) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599467 0.76 KMT2A (0.55) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599526 0.75 ALDH1A1 (0.53) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599510 0.75 KMT2A (0.53) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599531 0.74 KDM4E (0.44) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599533 0.74 KDM4E (0.44) KDM4EMEN1ALDH1A1HPGDKMT2A
SCHEMBL17599534 0.74 KDM4E (0.44) KDM4EMEN1ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback